Supplement_3_AlMukdad_et_al - Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic Review

Supplement_3_AlMukdad_et_al for Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic Review by Sawsan AlMukdad, Hazem Elewa and Daoud Al-Badriyeh in Journal of Cardiovascular Pharmacology and Therapeutics